 Echocardiographic assessment doxazosin left ventricular mass patients essential hypertension single daily dose doxazosin period significant reduction blood pressure ventricular mass index patients mild moderate hypertension systolic shortening coefficient trend improvement ejection fraction rate circumferential fiber shortening systolic contraction time preejective/ejective ratio change heart rate patients side effects serum lipid profile regard low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio reduction blood pressure ventricular mass serum lipid profile doxazosin beneficial change overall coronary heart disease risk profile